First joint meeting on antimicrobial resistance and healthcare-associated infectionsArchived

23 Nov 2011 - 25 Nov 2011
Warsaw, Poland

This was the first joint annual plenary meeting of the EARS-Net and HAI-Net participants and the National Antimicrobial Resistance Focal Points.

On 23-25 November 2011, ECDC organised the first Joint Annual Meeting of the Antimicrobial Resistance and Healthcare-associated Infections (ARHAI) Networks that was held in Warsaw, Poland.

The meeting addressed a wide range of issues concerning antimicrobial resistance (AMR) and healthcare-associated infections (HAI). Poland, as host nation and current EU presidency country, presented its experiences and successes with surveillance and control of HAI and AMR. The meeting further included fourteen separate network sessions related to activities of EARS-Net, HAI-Net and National AMR Focal points.

The HAI sessions were about surveillance of surgical site infections, infections in intensive care units, Clostridium difficile infections, as well as on the point prevalent surveys of HAI and antimicrobial use in acute care hospitals and in long-term care facilities, infection control training and the future of HAI surveillance.

The AMR sessions focused on prevention and control of carbapenemase-producing bacteria in healthcare facilities, the Epidemic Intelligence Information System (EPIS) module for AMR and HAI, and the future of AMR surveillance. The presentations and discussions on carbapenem resistance attracted much attention from all countries. The meeting also featured a session on how to link databases and an open session on TESSy and other surveillance software for data managers.

The meeting was attended by 221 participants that represented all EU Member States, Iceland, Norway, all the candidate and potential candidate countries, as well as representatives from the European Commission and WHO.


Meeting programme

List of participants 

Results of the meeting evaluation




Plenary Session 1: Experiences and successes from Poland

Dissemination of carbapenemase-producing Enterobacteriaceae in Poland, Marek Gniadkowski (National Medicines Institute, Warsaw)

MRSA reservoirs in Poland, Dorota Żabicka, (National Medicines Institute, Warsaw)

A road to effective infection control in Poland: from HELICS to HAI-Net, Piotr B. Heczko (Jagiellonian University Collegium Medicum Krakow)

Networks of hospitals: building a common strategy for HAI prevention and control and antimicrobial policy, Tomasz Ozorowski (University of Medical Sciences, Poznan)

Success of educational tools to control AMR in the community, Roman Kolek (Opolskie Voivodeship)

Polish barometer: knowledge of the Polish population about antibiotics, Waleria Hryniewicz (National Medicines Institute, Warsaw)

Plenary Session 2: Updates from the European Commission and ECDC

Update from the European Commission, Antoon Gijsens (EC/SANCO/C3)

Results from EARS-Net, Oler Heuer (ECDC)

Scientific advice: A European perspective on CPE: the necessity to turn the tide, Anna-Pelagia Magiorakos (ECDC)

ECDC public health microbiology strategy, Oler Heuer (ECDC)

Updated ARHAI web portal, Barbara Albiger (ECDC)

Other ECDC issues/Introduction to working groups, Dominique L. Monnet (ECDC)

Plenary Session 3: Reports from networks and working groups

EARS-Net, Nienke van de Sande (The Netherlands)

National AMR Focal Points, Dominique L. Monnet (ECDC)

Carbapenemase-producing bacteria, José Campos (Spain)

EPIS for AMR & HAI, Barbro Liljequist (Sweden)

Future of AMR surveillance, Gunnar Skov Simonsen (Norway)

HALT-2: HAI and antimicrobial use long-term care facilities, Jean-Michel Thiolet (France)

Infection control training, Nina Sorknes (Norway)

Plenary Session 4: Reports from networks and working groups

HAI-Net: Point prevalence survey, Carl Suetens (ECDC)

HAI-Net: Surgical site infections, Paulius Gradeckas (Hungary)

HAI-Net: Intensive care units, Antonella Agodi (Italy)

Surveillance of Clostridium difficile infections, Ed Kuijper (The Netherlands)

Data protection and linking databases, Carlo Gagliotti (Italy)

Future of HAI surveillance, Jacqui Rilley (UK-Scotland)


Session 1: HAI-Net: Point prevalence survey (PPS)

Overview of PPS in 2011: tools and reports, Carl Suetens (ECDC)

Comments of Network committee on HAI case definitions, Bruno Coignard (InVS, France), Carl Suetens (ECDC)

Pilot validation study of the PPS: experiences and feasibility, Jacqui Reilly (NHS/HP Scotland, UK) 

Session 2: EARS-Net

Status of EARS-Net and feedback regarding data collection, Ole Heuer (ECDC)

WHONET feedback, John Stelling (Brigham and Women's Hospital, USA)

Diagnostic challenges in detection of carbapenem resistance in AST surveillance, Christian Giske (KS/KI, Sweden)

Update of EARS-Net microbiological protocol, Marianne Gunell (ECDC)

EARS-Net EQA 2011, Derek Brown (HPA, UK)

EUCAST status on BP implementation, Gunnar Kahlmeter (Central Hospital Växjö, Sweden) 

Session 3: HALT-2: HAI and antimicrobial use in long-term care facilities

Hand hygiene improvement: a priority in long-term care facilities, Benedetta Allegranzi (WHO)

HALT Results PPS 2010, Katrien Latour (IPH, Belgium)

What next HALT-2, Béatrice Jans (IPH, Belgium)

HALT-2 PPS and software, Béatrice Jans, Katrien Latour (IPH, Belgium)

HAI and antimicrobial use in long-term care facilities: Kick off meeting HALT 2 project - Resident questionnaire

HAI and antimicrobial use in long-term care facilities: Kick off meeting HALT 2 project - Urinary tract infections

HALT-2 validation study, Maria Luisa Moro, Enrico Ricchizzi (ASR-Regione Emilia-Romagna, Italy)

HALT-2 train-the-trainers course and one-day course in LTCF, Fidelma Fitzpatrick (HSE, Ireland)

HALT 2 - Point Prevalence Survey 2013

Session 4: HAI-Net: Surgical site infections

Presentation of the results of the surveillance of surgical Site infection in Europe 2008-2009, Jolanta Griškevičienė (ECDC)

Presentation on the data quality, differences between countries and surveillance systems, data cleansing procedures, Jolanta Griškevičienė (ECDC)

Session 5: National AMR Focal Points (11th meeting)

Update on ECDC AMR & HAI activities and workplan 2012 and discussion, Dominique L. Monnet (ECDC)

Update on European Antibiotic Awareness Day and discussion, Dominique L. Monnet (ECDC)

Elements for a future ECDC strategy on AMR & HAI, Dominique L. Monnet (ECDC)

Session 7: Prevention and control of spread of carbapenemase-producing bacteria in healthcare facilities

Country perspective: France, Vincent Jarlier (PSL/APHP, France)

Carbapenemase-producing bacteria in Europe- update from ECDC and future directions, Anna-Pelagia Magiorakos (ECDC)

Country perspective: Italy, Maria Luisa Moro (ASR-Regione Emilia-Romagna, Italy)

Country perspective: Greece, Alkis Vatopoulos (NSPH, Greece)

Session 8: HAI-Net: Intensive care unit

Methodological issues in HAIICU protocol: discrepancies between HAIICU and HAIPPS protocol, Light denominator, Infection episodes, Alain Lepape (CHU Lyon, France)

Case studies of ICU-acquired infections

Session 9: Future of HAI surveillance

From HELICS I to HAI-Net, Jacques Fabry (CCLIN, Lyon, France)

New targets for HAI surveillance: introduction, Petra Gastmeier (IHEM, Charite University, Germany)

Example of electronic surveillance at local level: MONI system in the ICU, Alexander Blacky (University Hospital Vienna, Austria)

The Anti-Infection Tool, Petra Hasselqvist (Swedish Association of Local Authorities and Regions, Sweden)

Session 10: Epidemic Intelligence Information System (EPIS) & national early warning and response

Presentation of the new EPIS module for Antimicrobial Resistance and Healthcare-associated Infections (EPIS AMR-HAI), Niels Kleinkauf, Alberto Pedrini (ECDC)

How to monitor rare, severe or emerging HAI Implementation of a national HAI early warning and response system, France, Bruno Coignard (InVS, France)

The importance of national surveillance on antimicrobial resistance: the Dutch example Nienke van de Sande-Bruinsma (RIVM, The Netherlands)

Session 11: Infection control training

Where do we go for the future Developing infection control training in Europe, Carmen Varela Santos (ECDC)

Session 12: Future of AMR surveillance

Outputs of previous discussions on objectives and priorities for AMR surveillance, Ole Heuer (ECDC)

Future of AMR surveillance beyond EARS-Net, Hajo Grundmann (RIVM, The Netherlands)

WHO strategic action plan on antibiotic resistance in Europe Strengthening surveillance, Danilo Lo Fo Wong (WHO/Europe)

Session 13: Data protection and linking databases

What is personal data, Sergio Brusin (ECDC)

Overview of possible applications of linking databases at national and ECDC level, Carlo Gagliotti (ASR-Regione Emilia-Romagna, Italy)

ECDC data access policy, Sergio Brusin (ECDC)

Session 14: Surveillance of Clostridium difficile infection

CDI surveillance in Europe, Petra Gastmeier, Axel Kola (IHEM, Charite University Berlin)

Progress of ECDIS-Net and new aspects of the epidemiology of CDI, Ed Kujper (Leiden University Medical Centre, The Netherlands)